1. Home
  2. AIMD vs YOSH Comparison

AIMD vs YOSH Comparison

Compare AIMD & YOSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • YOSH
  • Stock Information
  • Founded
  • AIMD 1984
  • YOSH 2016
  • Country
  • AIMD United States
  • YOSH United States
  • Employees
  • AIMD N/A
  • YOSH N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • YOSH Restaurants
  • Sector
  • AIMD Health Care
  • YOSH Consumer Discretionary
  • Exchange
  • AIMD Nasdaq
  • YOSH Nasdaq
  • Market Cap
  • AIMD 6.0M
  • YOSH 5.6M
  • IPO Year
  • AIMD N/A
  • YOSH 2022
  • Fundamental
  • Price
  • AIMD $0.46
  • YOSH $3.65
  • Analyst Decision
  • AIMD
  • YOSH
  • Analyst Count
  • AIMD 0
  • YOSH 0
  • Target Price
  • AIMD N/A
  • YOSH N/A
  • AVG Volume (30 Days)
  • AIMD 132.1K
  • YOSH 31.2K
  • Earning Date
  • AIMD 11-06-2024
  • YOSH 11-19-2024
  • Dividend Yield
  • AIMD N/A
  • YOSH N/A
  • EPS Growth
  • AIMD N/A
  • YOSH N/A
  • EPS
  • AIMD N/A
  • YOSH N/A
  • Revenue
  • AIMD $40,633.00
  • YOSH $11,652,880.00
  • Revenue This Year
  • AIMD N/A
  • YOSH N/A
  • Revenue Next Year
  • AIMD N/A
  • YOSH N/A
  • P/E Ratio
  • AIMD N/A
  • YOSH N/A
  • Revenue Growth
  • AIMD N/A
  • YOSH 25.97
  • 52 Week Low
  • AIMD $0.40
  • YOSH $2.73
  • 52 Week High
  • AIMD $4.29
  • YOSH $8.46
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 49.75
  • YOSH 46.13
  • Support Level
  • AIMD $0.42
  • YOSH $3.64
  • Resistance Level
  • AIMD $0.48
  • YOSH $3.96
  • Average True Range (ATR)
  • AIMD 0.04
  • YOSH 0.30
  • MACD
  • AIMD 0.00
  • YOSH 0.07
  • Stochastic Oscillator
  • AIMD 36.48
  • YOSH 53.91

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About YOSH Yoshiharu Global Co.

Yoshiharu Global Co is a restaurant operator. The company has one reportable segment, consisting of operating its stores. Yoshiharu serves the perfect, ideal ramen, as well as offers customers a wide variety of sushi, bento menus, and other favorite Japanese cuisines. It owns and operates restaurant stores.

Share on Social Networks: